IPO Trending
AMWILLSME / BSEListed
Amwill Healthcare

Amwill Health Care Limited, founded in 2017, specializes in skincare, haircare, personal care, hygiene, and lip care products. The company focuses on innovative dermatological and cosmetic solutions but doesn’t manufacture products itself. Instead, it partners with third parties for production, testing, and distribution. Amwill sells exclusively to Amderma Healthcare LLP, which handles storage and order fulfillment. Currently operating in Karnataka, Andhra Pradesh, and Telangana, the company plans to expand to West Bengal and Odisha. With a team of 59 professionals, Amwill covers product development, marketing, sales, and administration.

₹105 - ₹1115.78x sub
Listed Price₹88.85
Listing Gain-19.95%

Subscription Status

5.78xTotal Demand
Updated 20 Oct 2026, 01:30 AM
QIB7.80x
Popular / Warm DemandOffered: 10,26,000 sh
Nib5.79x
Popular / Warm DemandOffered: 20,53,200 sh
Retail4.77x
Popular / Warm DemandOffered: 20,53,200 sh
CategoryOfferedAppliedTimes
QIB10,26,00080,01,6007.8x
Nib20,53,2001,18,92,0005.79x
Retail20,53,20097,89,6004.77x

Segment Subscription Demand

Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB88.8211.397.80x
Retail108.6622.794.77x
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Amwill Healthcare IPO Subscription Demand

Live subscription status and bidding analysis for Amwill Healthcare (AMWILL) IPO. The issue is subscribed 5.78x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions